Active Targeting Using HER-2-Affibody-Conjugated Nanoparticles Enabled Sensitive and Specific Imaging of Orthotopic HER-2 Positive Ovarian Tumors

Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic Cancer

(2013) Gee Young Lee et al.   ACS Nano

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

(2013) U. Prabhakar et al.   CANCER RESEARCH

HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas

(2012) Federica Guzzo et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles

(2012) Jaehong Key et al.   JOURNAL OF CONTROLLED RELEASE

Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model

(2012) G. Kramer-Marek et al.   JOURNAL OF NUCLEAR MEDICINE

Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging

(2012) Rafal Zielinski et al.   PLoS One

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

(2011) Gooitzen M van Dam et al.   NATURE MEDICINE

Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging

(2011) Boguslaw Tomanek et al.   NEURO-ONCOLOGY

PET/NIRF/MRI triple functional iron oxide nanoparticles

(2010) Jin Xie et al.   BIOMATERIALS

Affibody-based nanoprobes for HER2-expressing cell and tumor imaging

(2010) Jinhao Gao et al.   BIOMATERIALS

Near IR Heptamethine Cyanine Dye-Mediated Cancer Imaging

(2010) X. Yang et al.   CLINICAL CANCER RESEARCH

Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice

(2010) A. Cirstoiu-Hapca et al.   JOURNAL OF CONTROLLED RELEASE

T1-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles

(2010) Longjiang Zhang et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules

(2010) R. P. Baum et al.   JOURNAL OF NUCLEAR MEDICINE

Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer

(2010) R. De Souza et al.   MOLECULAR CANCER THERAPEUTICS

Imaging ovarian cancer and peritoneal metastases—current and emerging techniques

(2010) Stavroula Kyriazi et al.   Nature Reviews Clinical Oncology

Delivering nanomedicine to solid tumors

(2010) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting

(2009) Kai Chen et al.   BIOMATERIALS

Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer

(2009) L. Yang et al.   CLINICAL CANCER RESEARCH

Near-infrared fluorescence: application to in vivo molecular imaging

(2009) Scott A Hilderbrand et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional Nanoparticles

(2009) Lily Yang et al.   GASTROENTEROLOGY

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

(2009) A. Orlova et al.   JOURNAL OF NUCLEAR MEDICINE

Mediating Tumor Targeting Efficiency of Nanoparticles Through Design

(2009) Steven D. Perrault et al.   NANO LETTERS

Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles

(2009) Kenneth E. Scarberry et al.   Nanomedicine-Nanotechnology Biology and Medicine

HER-2-Targeted Nanoparticle-Affibody Bioconjugates for Cancer Therapy

(2008) Frank Alexis et al.   ChemMedChem

Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging

(2008) S. B. Lee et al.   CLINICAL CANCER RESEARCH

Does a targeting ligand influence nanoparticle tumor localization or uptake?

(2008) Kathleen F. Pirollo et al.   TRENDS IN BIOTECHNOLOGY